Samelisant - 10mM in DMSO , CAS No.1394808-20-8

CAS: 1394808-20-8 Cat. No.: S654980 Formula: C₂₁H₃₃Cl₂N₃O₃ Peso molecolare: 446.41 PubChem CID: 60151476

GRADE & PURITY 10mM in DMSO

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

Panoramica

Samelisant (SUVN-G3031) is a potent and selective histamine H3 receptor (H3R) inverse agonist with good brain penetration and oral bioavailability. Samelisant has a similar binding affinity towards human (hH3R; K i =8.7 nM) and rat (rH3R;K i =9.8 nM) H3R indicating no inter-species differences. Samelisant can be used for the research of sleep-related disorders.

In Vitro

Samelisant displays inverse agonist activity and it exhibits very high selectivity towards H3R. The pEC 50 value of histamine (8.5) for human H3 receptor increases to 8.2, 7.3 and 6.2 after treatment with 1, 10 and 100 nM of Samelisant, respectively. The pEC 50 value of histamine (8.2) for rat H3 receptor increases to 7.9, 7.4 and 6.4 after treatment with 1, 10 and 100 nmol/L of Samelisant, respectively. Samelisant binds to the orthosteric site in a reversible manner with K b values of 1.3 nM and 1.1 nM deduced from pA 2 value for human and rat H3R, respectively. Samelisant also modulates dopamine and norepinephrine levels in the cerebral cortex while it has no effects on dopamine levels in the striatum or nucleus accumbens. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Treatment with Samelisant (10 and 30 mg/kg, p.o.) produces a significant increase in wakefulness with a concomitant decrease in non-rapid eye movement sleep (NREM) sleep in orexin knockout mice subjected to sleep electroencephalography (EEG) . Samelisant also produces a significant decrease in direct rapid eye movement (REM) sleep onset (DREM) episodes, demonstrating its anticataplectic effects in an animal model relevant to narcolepsy . Samelisant treatment in mice produces a dose-dependent increase in tele -methylhistamine levels indicating the activation of histaminergic neurotransmission . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Wistar rats or male C57BL6J mice Dosage: 1, 3, 10, and 30 mg/kg Administration: Oral administration Result: Produced a dose-dependent increase in t-MH levels in the frontal cortex, hypothalamus and cerebrospinal fluid (CSF) of male Wistar rats.\nProduced a significant increase in t-MH levels of the frontal cortex, striatum and hypothalamus in mice.

Specifications

Specifiche e purezza

10mM in DMSO

Meccanismi biochimici e fisiologici

Samelisant (SUVN-G3031) is a potent and selective histamine H3 receptor (H3R) inverse agonist with good brain penetration and oral bioavailability. Samelisant has a similar binding affinity towards human (hH3R; K i =8.7 nM) and rat (rH3R;K i =9.8 nM) H3R

Condizioni di conservazione di stoccaggio

Store at -80°C

Spedito in

Dry ice packs + Cold packs

Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.

Nomi e identificatori

• Isomeri SMILES: C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)NC(=O)CN4CCOCC4.Cl.Cl
• PubChem CID: 60151476
• Peso molecolare: 446.41

Domande frequenti

How should this product be stored?

Store at ?80 °C. Ultra-low temperature storage is required to maintain the specified shelf life.

How is this product shipped?

This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.

What are the CAS number, molecular formula and molecular weight?

The CAS Number is 1394808-20-8, the molecular formula is C21H33Cl2N3O3, and the molecular weight is 446.41 g/mol.

What documentation is provided?

Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.